SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-026295
Filing Date
2024-06-03
Accepted
2024-06-03 16:03:35
Documents
15
Period of Report
2024-05-30
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf-20240530.htm   iXBRL 8-K 33162
2 EX-99.1 a991ex060324.htm EX-99.1 2038
6 crdf-20240530_g1.jpg GRAPHIC 2732
  Complete submission text file 0001628280-24-026295.txt   167172

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20240530.xsd EX-101.SCH 1925
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20240530_lab.xml EX-101.LAB 21673
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20240530_pre.xml EX-101.PRE 12536
18 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20240530_htm.xml XML 2707
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 241013537
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)